TrialFrontiers in immunology2026

A phase III clinical trial on the immunogenicity of a tetanus vaccine, adsorbed in individuals aged 18 years and above in China.

Qiuyue Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.